National Cancer Centre, Singapore

This study tests whether combining two drugs, osimertinib and S-1, can shrink tumors in people with a specific type of lung cancer (EGFR mutant) that has stopped responding to standard treatments. About 30 adults with advanced lung cancer will receive the combination and be monit…

This phase II trial tests whether combining two immunotherapy drugs, ipilimumab and nivolumab, can shrink tumors in people with advanced nasopharyngeal carcinoma (NPC) linked to the Epstein-Barr virus. About 113 patients with recurrent or metastatic NPC that can't be cured will r…

This study tests a drug called 177Lu-DOTATATE, which delivers radiation directly to cancer cells, in people with metastatic nasopharyngeal cancer that has not responded to at least two prior treatments. Only patients whose tumors show up on a special scan are eligible. The main g…

This study tests a new method called PIPAC that sprays chemotherapy directly into the abdomen as a fine mist. It is for people with advanced cancer that has spread to the lining of the belly and who cannot have surgery to remove it. The goal is to see if this approach is safe and…

This pilot study tests whether a trained Patient Support Coordinator (PSC) can help women with advanced breast cancer feel more heard and understood. Over three months, 28 participants will have regular supportive listening sessions alongside their usual medical care. The goal is…

This study collects and analyzes lung cancer tissue samples from 500 patients in Asia to find out which genetic changes are most common. The goal is to better understand the disease in the local population. Participants must have a tissue sample available and be healthy enough fo…